| Literature DB >> 33396603 |
Ping Gong1,2, Yifan Wang2, Pengfei Zhang1, Zhaogang Yang2, Weiye Deng2, Zhihong Sun1,3, Mingming Yang2, Xuefeng Li2, Gongcheng Ma1, Guanjun Deng1, Shiyan Dong2, Lintao Cai1, Wen Jiang2.
Abstract
Despite the advances in surface bioconjugation of synthetic nanoparticles for targeted drug delivery, simple biological functionalization is still insufficient to replicate complex intercellular interactions naturally. Therefore, these foreign nanoparticles are inevitably exposed to the immune system, which results in phagocytosis by the reticuloendothelial system and thus, loss of their biological significance. Immunocyte membranes play a key role in intercellular interactions, and can protect foreign nanomaterials as a natural barrier. Therefore, biomimetic nanotechnology based on cell membranes has developed rapidly in recent years. This paper summarizes the development of immunocyte membrane-coated nanoparticles in the immunotherapy of tumors. We will introduce several immunocyte membrane-coated nanocarriers and review the challenges to their large-scale preparation and application.Entities:
Keywords: T-cell; biomimicry; cancer immunotherapy; dendritic cell; immunocyte membrane-coated nanoparticles; macrophage; natural killer
Year: 2020 PMID: 33396603 DOI: 10.3390/cancers13010077
Source DB: PubMed Journal: Cancers (Basel) ISSN: 2072-6694 Impact factor: 6.639